You are here: Industry Insights > COVID-19 Vaccine

News List

SII pauses trials of COVID-19 vaccine candidate Covishield in India expresspharma
September 23, 2020
The company took this step after the DCGI issued a show cause notice to the company for not informing it about AstraZeneca pausing the clinical trials of the vaccine candidate in other countries.
Pfizer and BioNTech to potentially supply EU with 200 mn doses of COVID-19 vaccine candidate expresspharma
September 23, 2020
The proposed agreement also has an option to purchase additional 100 million doses, with deliveries starting by the end of 2020, subject to regulatory approval.
Statement on AstraZeneca Oxford SARS-CoV-2 Vaccine, AZD1222, COVID-19 Vaccine Trials Temporary Pause drugs.com
September 23, 2020
As part of the ongoing randomised, controlled clinical trials of the AstraZeneca Oxford coronavirus vaccine, AZD1222...
COVID-19 vaccine tablet induces systemic and mucosal immune responses europeanpharmaceuticalreview
September 23, 2020
The researchers suggest inducing a mucosal immune response may be crucial to protect against SARS-CoV-2 infection and that the tablet formulation could overcome several major challenges associated with injectable vaccines.
An overview of Indian COVID-19 vaccine supply and development europeanpharmaceuticalreview
September 22, 2020
Prashant Khadayate, Pharma Analyst at GlobalData, explains what the current state of the COVID-19 pandemic is in India and what vaccine options are currently under development/testing.
BioNTech to Receive Funding to Support COVID-19 Vaccine Program americanpharmaceuticalreview
September 22, 2020
BioNTech announced it will receive a grant of up to 375 million Euro from an initiative by the German Federal Ministry of Education and Research (BMBF) to support the accelerated development of SARS-CoV-2 vaccines.
Sanofi and GSK agree to supply Covid-19 vaccine doses to EU pharmaceutical-technology
September 22, 2020
Sanofi and GlaxoSmithKline (GSK) have signed an advanced purchase agreement with the European Commission (EC) to supply up to 300 million doses of their potential Covid-19 vaccine, following regulatory approval.
BioNTech to acquire Novartis site for Covid-19 vaccine production pharmaceutical-technology
September 21, 2020
BioNTech has signed a share purchase agreement with Novartis to acquire a manufacturing site to boost its messenger RNA (mRNA)-based BNT162 Covid-19 vaccine candidate production capacity.
GoI publishes research procedure for COVID-19 vaccine candidates expresspharma
September 21, 2020
Over 30 vaccine candidates are in different stages of development in the country.
BioNTech to buy site from Novartis to boost COVID-19 vaccine production expresspharma
September 18, 2020
The financial details of the transaction have not been revealed but the facility in Germany’s Marburg will be converted to be fully on stream in the first half of 2021 with annual production capacity up to 750 million mRNA vaccine doses.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page